A detailed history of Caption Management, LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Caption Management, LLC holds 64,400 shares of IMCR stock, worth $2.32 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
64,400
Previous 687,200 90.63%
Holding current value
$2.32 Million
Previous $21.6 Million 89.15%
% of portfolio
0.02%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$31.87 - $37.2 $9.06 Million - $10.6 Million
284,159 Added 158.3%
463,662 $16.8 Million
Q2 2025

Aug 14, 2025

BUY
$24.53 - $38.65 $3.68 Million - $5.8 Million
150,110 Added 510.7%
179,503 $5.63 Million
Q1 2025

May 15, 2025

BUY
$28.21 - $33.0 $829,176 - $969,969
29,393 New
29,393 $872,000
Q1 2024

May 15, 2024

BUY
$60.14 - $75.36 $554,009 - $694,216
9,212 New
9,212 $598,000
Q4 2022

Feb 14, 2023

BUY
$45.51 - $65.08 $546,120 - $780,960
12,000 New
12,000 $684,000

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.58B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.